Skip to main content

Advertisement

Log in

How Do Health Anxiety, Somatosensory Amplification, and Depression Levels Relate to Non-cyclical Mastalgia? A Case–Control Study

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Symptoms that are not completely explicable, such as mastalgia, might cause individuals to experience more apprehension regarding health and to visit doctors more frequently. No study has been found in the literature that assessed the level of somatosensory amplification of patients with mastalgia. This study is intended to assess the levels of somatosensory amplification of patients who complain of mastalgia and to compare them to a healthy control group. Forty patients with the diagnosis of non-cyclical mastalgia and 41 voluntary controls were incorporated in the study. All patients participating in the study were assessed using the Somatosensory Amplification Scale (SSAS), Health Anxiety Inventory (HAI), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI). The scores of SSAS, HAI, BAI, and BDI for the patient group were higher than those for the control group. Upon a simple regression analysis, the effect of education duration in mastalgia group on HAI was 12.4%, the effect of anxiety level on SSAS was 28%, and that of the depression level on HAI was 10.8%. Patients with mastalgia exhibited higher levels of somatosensory amplification, depression, anxiety, and health anxiety than the control group. The idiopathic symptoms might cause individuals to develop a higher level of somatosensory amplification and to perceive bodily symptoms more severely. Furthermore, such symptoms might further produce anxiety and depressive symptoms due to the higher perception by the individuals with apprehension related to their health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kataria K, Dhar A, Srivastava A, Kumar S, Goyal A (2014) A systematic review of current understanding and management of mastalgia. Indian J Surg 76:217–222. https://doi.org/10.1007/s12262-013-0813-8

    Article  PubMed  Google Scholar 

  2. Hafiz SP, Barnes NLP, Kirwan CC (2018) Clinical management of idiopathic mastalgia: a systematic review. J Prim Health Care 10:312–323. https://doi.org/10.1071/HC18026

    Article  PubMed  Google Scholar 

  3. Preece PE, Mansel RE, Hughes LE (1978) Mastalgia: psychoneurosis or organic disease? BMJ 1:29–30. https://doi.org/10.1136/bmj.1.6104.29

    Article  CAS  PubMed  Google Scholar 

  4. Jenkins PL, Jamil N, Gateley C, Mansel RE (1993) Psychiatric illness in patients with severe treatment-resistant mastalgia. Gen Hosp Psychiatry 15:55–57

    Article  CAS  Google Scholar 

  5. Ader DN, South-Paul J, Adera T, Deuster PA (2001) Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 22:71–76

    Article  CAS  Google Scholar 

  6. Demirel Yılmaz E, Deveci E, Kadıoğlu H et al (2014) Anxiety and depression levels and personality traits of mastalgia patients. J Psychiatry 17:118. https://doi.org/10.4172/Psychiatry.1000118

    Article  Google Scholar 

  7. Topçuoğlu V, Kuşçu MK, Gımzal A et al (2003) Alexithymia, depression and anxiety levels in mastalgia patients: a controlled study. Yeni Symp 41:178–181

    Google Scholar 

  8. Barsky AJ, Goodson JD, Lane RS, Cleary PD (1988) The amplification of somatic symptoms. Psychosom Med 50:510–519

    Article  CAS  Google Scholar 

  9. Köteles F, Witthöft M (2017) Somatosensory amplification – an old construct from a new perspective. J Psychosom Res 101:1–9. https://doi.org/10.1016/j.jpsychores.2017.07.011

    Article  PubMed  Google Scholar 

  10. Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    Article  CAS  Google Scholar 

  11. Hisli N (1988) Beck depresyon envanteri’nin geçerliği üzerine bir çalışma. Türk Psikol Derg 22:118–126

    Google Scholar 

  12. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897

    Article  CAS  Google Scholar 

  13. Ulusoy M, Sahin NH, Erkmen H (1998) Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cogn Psychother 12:163–172

    Google Scholar 

  14. Barsky AJ, Wyshak G, Klerman GL (1990) The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 24:323–334

    Article  CAS  Google Scholar 

  15. Güleç H, Sayar K (2007) Reliability and validity of the Turkish form of the Somatosensory Amplification Scale. Psychiatry Clin Neurosci 61:25–30. https://doi.org/10.1111/j.1440-1819.2007.01606.x

    Article  PubMed  Google Scholar 

  16. Salkovskis PM, Rimes KA, Warwick HMC, Clark DM (2002) The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 32:843–853

    Article  CAS  Google Scholar 

  17. Aydemir Ö, Kirpinar İ, Sati T, Uykur B, Cengisiz C (2013) Reliability and validity of the Turkish version of the Health Anxiety Inventory. Arch Neuropsychiatry 50:325–331. https://doi.org/10.4274/npa.y6383

    Article  Google Scholar 

  18. Kanat BH, Atmaca M, Girgin M, Ilhan YS, Bozdağ A, Özkan Z, Yazar FM, Emir S (2016) Effects of mastalgia in young women on quality of life, depression, and anxiety levels. Indian J Surg 78:96–99. https://doi.org/10.1007/s12262-015-1325-5

    Article  PubMed  Google Scholar 

  19. Khan SA, Apkarian AV (2002) The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat 75:147–157. https://doi.org/10.1023/A:1019685829799

    Article  PubMed  Google Scholar 

  20. Holland PA, Gateley CA (1994) Drug therapy of mastalgia. Drugs 48:709–716. https://doi.org/10.2165/00003495-199448050-00005

    Article  CAS  PubMed  Google Scholar 

  21. Colegrave S, Holcombe C, Salmon P (2001) Psychological characteristics of women presenting with breast pain. J Psychosom Res 50:303–307. https://doi.org/10.1016/S0022-3999(01)00196-9

    Article  CAS  PubMed  Google Scholar 

  22. Aksu G, Hocaoğlu Ç (2004) The study of alexithymia, anxiety, worry and depression levels of the patients who suffered by mastalgia and underwent to radiodiagnostic assay. Klin Psikiyatr 7:95–102

    Google Scholar 

  23. Simon GE, VonKorff M (1991) Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study. Am J Psychiatry 148:1494–1500. https://doi.org/10.1176/ajp.148.11.1494

    Article  CAS  PubMed  Google Scholar 

  24. Kumar V, Avasthi A, Grover S (2018) Somatosensory amplification, health anxiety, and alexithymia in generalized anxiety disorder. Ind Psychiatry J 27:47–52. https://doi.org/10.4103/ipj.ipj_72_17

    Article  PubMed  PubMed Central  Google Scholar 

  25. Yavuz BG, Aydinlar EI, Dikmen PP, Incesu C (2013) Association between somatic amplification, anxiety, depression, stress and migraine. J Headache Pain 14:53. https://doi.org/10.1186/1129-2377-14-53

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kivrak Y, Kose Ozlece H, Ustündag MF, Asoglu M (2016) Pain perception: predictive value of sex, depression, anxiety, somatosensory amplification, obesity, and age. Neuropsychiatr Dis Treat 12:1913–1918. https://doi.org/10.2147/NDT.S106974

    Article  PubMed  PubMed Central  Google Scholar 

  27. Torvik FA, Ystrom E, Czajkowski N, Tambs K, Røysamb E, Ørstavik R, Knudsen GP, Kendler KS, Reichborn-Kjennerud T (2015) Socioeconomic status and sick leave granted for mental and somatic disorders: a prospective study of young adult twins. BMC Public Health 15:134. https://doi.org/10.1186/s12889-015-1457-3

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lipowski ZJ (1990) Somatization and depression. Psychosomatics 31:13–21. https://doi.org/10.1016/S0033-3182(90)72212-8

    Article  CAS  PubMed  Google Scholar 

  29. Eren T, Aslan A, Ozemir IA, Baysal H, Sagiroglu J, Ekinci O, Alimoglu O (2016) Factors effecting mastalgia. Breast Care 11:188–193. https://doi.org/10.1159/000444359

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Cicek Hocaoglu for the scientific editorial assistance.

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yunus Hacimusalar.

Ethics declarations

The study was approved by the local Ethics Committee of Yozgat Bozok University with a protocol number of 2017-KAEK-189_2018.06.06_04 and performed under the ethical principles of the Declaration of Helsinki for medical research involving human subjects.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hacimusalar, Y., Talih, T. & Karaaslan, O. How Do Health Anxiety, Somatosensory Amplification, and Depression Levels Relate to Non-cyclical Mastalgia? A Case–Control Study. Indian J Surg 82, 578–584 (2020). https://doi.org/10.1007/s12262-019-02014-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-019-02014-y

Keywords

Navigation